chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme fatigue. Inability to stay awake past 5:00 PM in the afternoon. Very high blood sugar.
Possible sycope. After recieving both vaccines, pt was exiting the store and fainted at the front of the store. Pt was caught by other employee before being brought to the ground. Unclear if pt lost consciousness but if did was only briefly. Vitals recorded, HR 56 BPM and BP 112/72. Pt reported lack of addiquate hydration which could have lead to event. Bottle of water provided to the pt and was monitored for about 5 minutes. Pt refused 911 and any additional medical support. Pt was gradually brought to seated position, then to standing before being walked out to car. Advised pt to seek further medical assistance if symptoms reoccur.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 24-NOV-2012, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster or shingles. On or about 09-AUG-2016, the patient was treated by a facility for the onset of a severe vesicular rash, which was diagnosed as shingles. On or about 12-OCT-2016, the patient sought subsequent from the same facility for the onset of a severe vesicular rash, which was diagnosed as herpes zoster and post herpetic neuralgia, a chronic condition of pain and nerve damage secondary to herpes zoster infections. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
5 hours after 2 month vaccinations, patient projectile vomited, turned a grey-blue color, shallow breathing, staring, rapid heart rate, low oxygen level.
Dizziness, weakness, rapid heart rate suddenly set in at about 9:45pm. By 10 I was unable to remain standing and laid down to go to sleep. At 4am I woke up with no symptoms.
she has had severe headaches since; This is a Spontaneous report from a contactable consumer (patient herself). A 63-year-old female patient received of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: Unknown, Expiry date: unknown), via unspecified route of administration on 18Feb2021 as 2nd dose, single dose for COVID-19 immunisation. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE for COVID-19 Immunisation. Medical history included brain neoplasm from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 18Feb2021, since the evening of her vaccine, she experienced severe headaches. Caller states she was healthy prior to receiving the vaccine and she has accumulated a lot of medical bills since receiving the vaccine. Unable to offer survey caller disconnected call. States she was taking Tylenol regularly but it didn't really help so she stopped, and 3 days later she had a tremendous headache. States she has gone to the doctor, urgent care, and the ER. States they also did tests to rule out a brain tumour because even with meds, she gets very little relief. Therapeutic measures were taken as a result of adverse event. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
mild headaches after both shots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "mild headaches after both shots".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rt middle finger, rt wrist & lower arm aching, could not raise legs, has sharp pain in calves of legs esp on rt, knees swollen;
Exhaustion; Pain in arm; very sleepy; Coughing; This is a spontaneous report from a contactable consumer (patient). The consumer reported events for 2 patients. This is report 1 of 2. A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration on 11Mar2021 (at the age of 60-year-old) as single dose for COVID-19 immunization. Medical history included chronic fatigue syndrome, a lot of times the patient got ill with bacterial infections. Concomitant medication included sleep aid (unspecified). The patient had her first dose of the covid vaccine on 11Mar2021. The patient had underlying conditions and had chronic fatigue syndrome. The patient had been exhausted, had pain in her arm and coughing in Mar2021. The patient wanted to know if this was normal because her reaction, it made her very sleepy, like she was falling asleep and couldn't get up. The patient would fall asleep watching TV, she felt very tired but had sleep aid so its hard to tell if it was an attack on that or what. It's been 5 or 6 days, almost a week since they had the vaccine. The patient just had the first vaccine, they felt kind of bad. Just in case there's bacteria, in case the doctor prescribes an antibiotic, if they needed it, for say and for an upper respiratory infection. If you need antibiotics for pneumonia or sinus infection or respiratory infection, the patient wanted to make sure its okay to take antibiotics in-between the two doses of the vaccine. The patient got very sick very easily. Its a week later and the patient husband was concerned because of the mechanism of the vaccine and the immune system being challenged. It was not an underactive immune system, and a lot of times the patient and her husband get ill with bacterial infections. They wanted to know if they should avoid antibiotics. The husband knows one could not avoid them if one need them but enquired if there are any contraindications for that. The outcome of all the events were unknown.  No follow-up attempts are possible: Information about lot/batch number cannot be obtained.
1 or 2 days after vaccination administration - tender & swollen breasts ( bra no longer fit & was visually obvious to family & close friends  )  - lasted about 10-14 days.   Menstruation delayed about 2 weeks.    Menstruated (very light ) for a few days ( usually 7 days) then mensuration stopped for a week  and resumed for a few days.   I had no other side effects at all & usually do very well with vaccines.  I wasn?t going to mention it - figured- no big deal due to my age (possibly pre-menopause), but then a friend told me that 2 of her co-workers (RNs) had experienced noticeable changes to their cycle as well & I figured I should report it - thinking of younger women & reproduction.  My cycle has been unpredictable since - maybe menopause- but observed the coincidence
fever; diarrhea; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 28Feb2021 11:00 (Lot number: EN6198) at the age of 68 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension", start date: 1995 (ongoing); "A-fib", start date: 2010 (ongoing). Concomitant medication(s) included: METOPROLOL taken for atrial fibrillation (ongoing); LISINOPRIL taken for hypertension (ongoing); ELIQUIS taken for atrial fibrillation (ongoing); HYDROCHLOROTHIAZIDE taken for hypertension. Vaccination history included: Bnt162b2 (Dose 1, Date: 07Feb2021, Time: 13:00 , Anatomical site of injection: L arm, Route of administration: Intramuscular, Batch/Lot number: EL9269), administration date: 07Feb2021, when the patient was 68 years old, for Covid-19 Immunization.  The following information was reported: DIARRHOEA (non-serious) with onset 28Feb2021, outcome "recovered" (01Mar2021), described as "diarrhea"; PYREXIA (non-serious) with onset 01Mar2021, outcome "recovered" (01Mar2021), described as "fever". Therapeutic measures were not taken as a result of diarrhoea, pyrexia.  Additional Information: It was reported that Pfizer product had a casual effect to the adverse event. No prior vaccination.  No follow-up attempts are possible. No further information is expected.
Incorrect dose of vaccine was given. 0.3ml was given 0.2ml should of been given.
Breakthrough case admission after 3 vaccines  Moderna 1/20/21 Lot# 032H20A;  Moderna 2/17/21 Lot# 026L20A;  Moderna 2/17/22 Lot# 028K21A
Significant myalgia in legs affecting functionality >50% within weeks and lasted months slowly subsided by October 2021
cried x 3 hrs inconsolably several hrs p/vax; was very very sleepy in next 24 hrs; then returned to nl activity;
No symptoms. Patient was given the pediatric instead of the adult dose of Hepatitis A. He was informed that he should get an adult dose in 6 months, and a booster in one year. He was informed that he will not have full immunity against Hep A.
Diagnosis:  Pityriasis rosea Symptoms started with a single small itchy red spot and grew to spots all over chest, abdomen and back Treatment ongoing with phototherapy sessions 2-3x per week at dermatologist
Rash on Injection site arm that started 3 days post injection  Headache   Tachycardia
1  month after second dose of the COVID 19 moderna vaccine i developed hazzy /foggy vision associated with headache right > left side and i was evaluated by ophthalmology and all were normal , also was evaluated by ENT and was suspected sinusitis and has been on antibiotics for 10 days now now the right headache has moved to the left side , the hazy vision has gotten better but the headache is persistent and does not respond to OTC medications . Similar symptoms in colleagues 1 month after the 2nd dose of the vaccine .
Within minutes of receiving the vaccine (Pfizer-BioNTech COVID-19 Vaccine EUA), my heart rate elevated to around 133/135 bpm. Dry mouth and sweats followed. Symptoms lasted around 30 minutes. Roughly 60 minutes after vaccine was administered, heart rate gradually decreased to around 100 bpm (with the help of breathing exercises). Another 20-30 minutes later, heart rate fell to around 84 bpm. The rest of the evening/night, heart rate steadied in the 70s. Normal heart rate while awake (between 62 and 65 bpm) followed the next day.
nausea; hard to move around; Vomiting; right side is dysfunctional and weak,; feel drunk; diagnosed with thrush mouth or yeast; tongue diagnosed to thrush; This is a spontaneous report received from a contactable consumer (patient). A 71-year-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EL9265, Expiration date unknown) dose 1, via an unspecified route of administration, administered in Arm Right on 28Jan2021 as single (at the age of 71-year-old) for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced tongue diagnosed to thrush and diagnosed with thrush mouth or yeast on 29Jan2021, right side is dysfunctional and weak and feel drunk on 12Feb2021, vomiting on 14Feb2021 and then nausea and hard to move around on an unspecified date. It was reported as, the patient received her first dose on 28Jan2021, the following day on 29Jan2021, she went to urgent care, had rash on her tongue, diagnosed with thrush mouth or yeast, states she treated that and it got better around 10Feb2021 or 12Feb2021. The patient states right side is dysfunctional and weak, feel drunk, nausea, and hard to move around hard to do things correctly and not make a mess, states it is hard for her to adjust. States this started on Friday 12Feb2021, States on 11Feb2021, she went to her stomach doctor and did not complain about that so she believes it started on 12Feb2021. States she also has vomited some the past two nights. States she is due for second dose tomorrow. Wants to know if these symptoms are related to the vaccine. States she is going to see a heart doctor tomorrow. Caller states she does have a bad back and neck that she will take medication for, does not know if this is related. Diagnosed with bad back and neck, sees pain management doctor for neck and shoulders. No further information provided. The patient underwent lab tests and procedures which included weight: 110-112 lbs on an unspecified date. Therapeutic measures were taken as a result of tongue diagnosed to thrush. The outcome of the events tongue diagnosed to thrush was recovering, for vomiting not recovered and while for outcome of other events were unknown.   Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Cannot taste Sweet. Pure Sugar has no flavor! Had a fast heart rate for about an hour that started 4 hours after injection. Also had a few sweats which were over in 8 hours.
On evening following vax, the pt's left thigh was slightly erythematous and swollen. By the following morning, swelling and erythema were worse. One and a half days post vax, the pt had developed a 7 1/2 x 13 1/2 cm area of erythema and induration. Treated with cool compresses and Tylenol.
Stroke; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's daughter) reported that a 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration, administered in Arm Left on 08Apr2021 10:15 (Lot Number: EW0151) (at the age of 68-year-old) as dose 1, single for COVID-19 immunisation.  Medical history included ongoing kidney disease from Jan2021, he was at the final stage of kidney disease, ongoing hypertension for years, since he was a kid, arthritis.  The patient's concomitant medications were not reported.  The patient previously received hepatitis vaccine and influenza vaccine on 01Mar2021 and experienced no AE.  The patient received his first dose of BNT162B2 08Apr2021, later had a stroke at an evening around 18:00 in the end of Apr2021 and missed his second dose of the vaccine. Stroke required a visit to emergency room but not physician office.  The patient was hospitalized for stroke from Apr2021 to Jun2021 for 60 days with rehabilitation and all of that.  The patient was home now from the hospital.  He didn't get the vaccine with his primary doctor. They were told that his stroke wasn't because of the vaccine. They were told what they assumed of how the stroke happened. The patient underwent lab tests and procedures which included continuous bloodwork in the hospital to check the levels of his kidneys and to check various things because he had the stroke with unknown results in 2021. He had CAT scans done with unknown results in 2021 because he had a minor brain bleed. He had X-rays with unknown results in 2021 also because he has arthritis.  Body height: 173 cm in 2021, weight: 90.72 kg in 2021.  Outcome of the event was unknown.
PT DID NOT REPORT THIS REACTION UNTIL 7/9/21. SHE HAS HAD TELANGIECTASIA MACULARIS ERUPTIVA PERSTANS ON HER UPPER BACK FOR YEARS, BUT AFTER HER FIRST DOSE PT NOTED A NEW AREA FORM ON HER LOWER BACK AND UPPER BUTTOCK AREA. IT IS ITCHY. DAYS VARY WITH ITCHINESS AND IT NEVER GOES AWAY.
The patient's concomitant medication included adalimumab (HUMIRA); The patient's concomitant medication included adalimumab (HUMIRA); 24hr headache occurred after each vaccine dose; This is a spontaneous report from a contactable nurse (patient).  A 52-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH1284), intramuscular at deltoid right on 07Jan2021 at 10:30 at single dose for COVID-19 immunization. The patient medical history included mild coronary artery disease (CAD), allergy to sulfa and seasonal allergy, all from an unknown date and unknown if ongoing. The patient's concomitant medication included finasteride at 1 mg, clonazepam at 0.5 mg, cetirizine hydrochloride (ZYRTEC) at 10 mg, aspirin at 81 mg, fremanezumab (AJOVY) at 125 g monthly and adalimumab (HUMIRA) twice weekly. The patient previously received MMR/Flu vaccine for immunization and experienced brachial plexus neuritis (parsonage Turner syndrome). The patient previously received first dose of (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular at deltoid right on 17Dec2020 at 10:30 at single dose for COVID-19 immunization and experienced tachycardia, elevated blood pressure (BP), headache and flushing face turned into red. In Jan2021, the patient experienced 24 hours headache. The patient outcome of the event was recovered.
pt recvd vax 11MAY94 & the same day exp a sore inj site, followed by redness & swelling;approx 48 to 72 hrs later the armpit of injected arm became sore to touch w/inflamed lymph nodes;sore armpit resolved on 18MAY94;pt recovered
Information has been received from a licensed practical nurse, for the Pregnancy Registry for GARDASIL, concerning an 18 year old female with no history of chicken pox and had negative varicella titers who on 27-OCT-2007 was vaccinated with a first dose of GARDASIL. On 20-OCT-2009, the patient was vaccinated with a second dose of GARDASIL. On 05-JAN-2010, the patient was vaccinated with a third dose of GARDASIL. There was no concomitant medication. After the third dose of vaccine was administered, the patient asked nurse for a pregnancy test. Urine pregnancy test performed on 05-JAN-2010 and the patient was pregnant. The patient was not experiencing any adverse effects. LMP was 25-NOV-2009; EDD was 31-AUG-2010. The patient sought unspecified medical attention. Follow-up information has been received from the licensed practical nurse concerning the 18 year old female (also reported as 19 year old) with no illness at time of vaccination and no any pre-existing allergies, birth defects or medical conditions and no previous pregnancies who on 20-OCT-2009 was vaccinated with a second dose of GARDASIL (LOT# 663454/0672Y) and on 05-JAN-2010 was vaccinated with a third dose of GARDASIL (route: intramuscularly, LOT# 661841/0653X). On 02-FEB-2010, a scheduled ultrasound was found the patient was pregnancy 12 weeks. On 18-MAR-2010, when the screening test of Maternal Serum Alpha-Fetoprotein Screening (MSAFP) revealed it was positive; however wrong due date was used "MSAFP" recalculated was normal. The patient had complication during pregnancy and delivery included onset of gestational diabetes and arrest of dilatations during the delivery; antenatal testing was performed two times weekly. Patient was treated with HUMALOG and HUMULIN for gestational diabetes during pregnancy. On 28-AUG-2010 at LMP of 39 weeks and 3 days, the patient delivered a normal, male infant, weight 9 pounds and 1 ounce and without congenital anomalies and other complications or abnormalities. No further information is available.
This case was reported by a consumer via call center representative and described the occurrence of international normalized ratio increased in a 63-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included open heart surgery. Concomitant products included carvedilol, COUMADIN, PLAVIX, spironolactone and fluoxetine. In June 2018, the patient received the 1st dose of SHINGRIX .5 ml. On 14th June 2018, less than a week after receiving SHINGRIX, the patient experienced international normalized ratio increased. On an unknown date, the outcome of the international normalized ratio increased was recovered/resolved. It was unknown if the reporter considered the international normalized ratio increased to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received the SHINGRIX vaccine about a week before the date of reporting. On Thursday, 14th June 2018, the patient went have her INR tested and it was over 8. It normally was 2.3. The patient's heart doctor was called and wanted her to go to the hospital however she stopped the COUMADIN, ate a lot of foods with Vitamin K and when she went the date of reporting to have her INR tested, her levels were normal. The patient had started back on the COUMADIN.
Information has been received from a physician concerning a female with eczema who about 1 year ago, was vaccinated with the first dose of GARDASIL, 0.5 mL, intramuscularly (lot number not reported). It was reported that the patient developed a persistent dry cough immediately after receiving the GARDASIL. The cough is worse at night but does not wake the patient. She experienced dizziness and weakness immediately after administration of the vaccine but the symptoms were resolved in 2 days without treatment. The patient did not return to the office to complete the vaccine series. They physician has scheduled the patient for an office evaluation. The physician did not think that the vaccine caused the persistent dry cough, and the patient will be worked up for allergies. Patient not recovered from persistent drug. Additional information has been requested.
Patient got her first moderna dose on 5/6/21, administered by immunizing certified tech. Patient returned on 5/16/21 and a had red itchy patch, about 1.5 inch in diameter, below the injection site. She feels itchiness and soreness. She has been taking tylenol but she claims it is not working.  She will take benadryl to help reduce the itchiness and redness and apply cool compresses to reduce soreness for the next couple days. Patient was advised if symptoms worsen or do not resolve within the next 3 days, patient should seek will seek medical attention.
Swollen left arm below injection site around the bicep/elbow area in the anterior section of arm for 1.5 days, +erythema, +pain. No fevers. Taking ibuprofen for pain.
Unauthorized use of Moderna Covid Vaccine in a 17 year old. No adverse reaction reported
I had not had a period since October of 2020.  I was experiecing all the signs of menopause.  Hot flashes, no menses, etc.  On 5/15, I began a very small period.  I thought it might be a fluke.  43 days later on June 26, 2021 I began a heavy period.  It is still ongoing as I write this.  Along with this period came, what seems to be, neuropathy.  I am having extreme pain in my right hip and leg that I also experienced with the 2nd dose of the vaccine which lasted for several weeks.  My periods prior to October 2020 had slowed down and were quite simple after several years of the periods like the one I'm having now.  I don't know if this is temporary or if I've been completely knocked out of menopause and am having to walk through peri-menopause all over again.
Around 9:00 pm I began to get a fever. It was a fever of 103 degrees. I took some Tylenol. I called my doctor the next morning and was told they were normal side-effects. In about a couple a days I felt better.
24 hours after administration of vaccine , she began to swell, turned red, non-tender - 5 inches of erythema induration